There are at least three areas—identifying suicide risk, predicting antidepressant response, and understanding genetic polymorphisms and their association with psychiatric risk—in which experts are using artificial intelligence to advance precision psychiatry.
No takes yet. Share an insight, caveat, or question.
Mark Moran (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: